Susan Dent

Nov 8, 2024 | oncologynewscentral.com | Rohit Gosain |Rahul Gosain |Susan Dent

slide, 1 of 2 is in view. Palliative & Supportive CareVideoThe Oncology Brothers – Rohit Gosain MD, and Rahul Gosain, MD – welcome palliative medicine specialists Janet Abrahm, MD, of Dana-Farber Cancer Institute Harvard School of Medicine, and Ishwaria Subbiah, MD, of the Sarah Cannon Cancer Network, to discuss the evolution and “normalizing” of palliative care in oncology.

Jul 25, 2024 | cancernetwork.com | Heather Moore |Avirup Guha |Irene Arias |Stella Stergiopoulos |Benjamin Li |Michael G. Fradley | +3 more

BackgroundThe prevalence of preexisting cardiovascular (CV) comorbidities at diagnosis of hormone receptor-positive (HR+)/HER2-negative (HER2–) metastatic breast cancer (mBC) has not been well established. We aimed to describe the prevalence of preexisting CV comorbidities in patients with newly diagnosed HR+/HER2– mBC and to describe the first documented cancer treatment and concurrent medications with risk of QT interval (QTc) prolongation for patients with or without CV comorbidities.

Jul 1, 2024 | jacc.org | Massimiliano Camilli |Carlo Maria Cipolla |Susan Dent |Giorgio Minotti

Introduction Since the 1980s, anthracyclines, including doxorubicin, daunorubicin, epirubicin, and idarubicin, have been central to treating various hematologic and solid malignancies, such as Hodgkin lymphoma (HL), non-Hodgkin lymphoma (nHL), acute leukemias, breast cancer (BC), ovarian cancer, and sarcomas.1,2 In clinical practice, the application of anthracyclines is limited by a dose-dependent cardiotoxicity, leading to both systolic and diastolic cardiac dysfunction and, in less common...

Jun 22, 2024 | acsjournals.onlinelibrary.wiley.com | Susan Dent |Robin Tumlinson |Avirup Guha |Heather Moore

CONFLICT OF INTEREST STATEMENT Susan Dent reports consulting for AstraZeneca, Pfizer, F. Hoffmann-La Roche, Bristol-Myers Squibb, Gilead Sciences, Eli Lilly, and Novartis. Avirup Guha reports being a ZERO Cancer Health Equity Task Force member, American Heart Association Council on Clinical Cardiology and Genomics and Precision Medicine Cardio-Oncology Committee member and site principal investigator, and Myovant, Pfizer, and Novartis Advisory Board member.

Mar 1, 2024 | cancernetwork.com | Carey Anders |Heather Moore |Rani Bansal |Susan Dent

2 Commerce Drive Cranbury, NJ 08512